Investigating the impact of regulatory variation on development through trans-regulation of 3D genome contacts.
Genetic variation between individuals in a population promotes distinct physical, behavioral, and molecular phenotypes. The molecular mechanisms by which genetic variation allows for differences in regulation of gene expression, remain poorly understood. Previous work from the Baker laboratory demonstrated genetic variation in mouse embryonic stem cells (mESCs), from C57BL/6J (B6) and DBA/2J (D2), impacts cell state transitions through chromatin regulation. Quantitative trait locus (QTL) mapping identified several trans-acting loci that co-regulate chromatin accessibility and gene expression. Currently, the role trans-regulation has on three-dimensional (3D) interactions as a mediator of this coordinated regulation is unknown. By leveraging the power of molecular techniques and genomics alongside genetically diverse biological samples, I am investigating how trans-regulation of chromatin impacts 3D interactions in development. Furthermore, I will expand on these observations to gain novel insight into understanding whether repressive factors, like KZFPs, can alter 3D genome contacts, how 3D interactions are regulated in trans, and the relationship between chromatin accessibility and 3D contacts.
Education
Tufts University and The Jackson Laboratory
PhD, Mammalian Genetics
Adv: Dr. Christopher Baker
2019-Present
Endicott College
BS
Biology & Biotechnology
2010-2014
Experience
The Jackson Laboratory
Predoctoral Associate
Dr. Christopher Baker
2019-present
Veritas Genetics
Molecular Medical Technologist III
2014-2019
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.